Osaka Univ. OKs iPS-Linked Clinical Study for Corneal Damage

Society Lifestyle Science

Osaka, Dec. 26 (Jiji Press)--An Osaka University team obtained on Wednesday broad approval for its plan to conduct a clinical study on a method to treat patients with damaged cornea by transplanting cells made from induced pluripotent stem, or iPS, cells from other people.

Following the green light from a related screening committee of the western Japan university, the team will file for health ministry approval for the study.

If approved, the team hopes to carry out the first transplant surgery in May or June next year.

Four patients aged 20 or over with serious symptoms of a disease called corneal epithelial stem cell deficiency are slated to participate in the study.

The cornea is the transparent portion of the outer fibrous coat of the eyeball. If corneal stem cells are lost due to injury or disease, its transparency will also be lost, leading to a drop in visual acuity and possible blindness.

[Copyright The Jiji Press, Ltd.]

Jiji Press